Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)

被引：1
|
作者：
Hansen, O. [1 ]
Knap, M. [2 ]
Khalil, A. [2 ]
Nyhus, C. [3 ]
Brink, C. [4 ]
Hoffmann, L. [5 ]
Schytte, T. [1 ]
机构：
[1] Odense Univ Hosp, Oncol, Odense, Denmark
[2] Aarhus Univ Hosp, Oncol, Aarhus, Denmark
[3] Vejle Hosp, Oncol, Vejle, Denmark
[4] Odense Univ Hosp, Lab Radiat Phys, Odense, Denmark
[5] Aarhus Univ Hosp, Med Phys, Aarhus, Denmark
来源：
RADIOTHERAPY AND ONCOLOGY | 2017年 / 123卷
关键词：
D O I：
10.1016/S0167-8140(17)31664-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1229
引用
收藏
页码：S663 / S663
页数：1
相关论文
共 50 条
  • [41] Concurrent Chemoradiotherapy (ConCRT) using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)
    Charalambous, H.
    Constantinou, I.
    Vomvas, D.
    Katodritis, N.
    Orphanos, G.
    Kyriacou, F.
    Porfiridis, I.
    Decatris, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S854 - S854
  • [42] Docetaxel (D, Taxotere®) with concurrent radiation in locally advanced non-small cell lung cancer (NSCLC)
    Aamdal, S
    Hagen, I
    Avril, I
    Lauvvang, G
    Owre, K
    Hatlevoll, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S260 - S260
  • [43] CONCURRENT CHEMORADIOTHERAPY (CONCRT) USING CISPLATIN-VINORELBINE IN LOCALLY ADVANCED (LA) NON-SMALL CELL LUNG CANCER (NSCLC)
    Charalambous, Haris
    Katodritis, Nicos
    Vomvas, Demetrios
    Maimaris, Michalis
    Decatris, Marios
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1154 - S1154
  • [44] Phase II trial of erlotinib maintenance therapy after platinun-based chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Cobo, M.
    Martinez, J.
    Montesa, A.
    Gil-Calle, S.
    Villar-Chamorro, E.
    Ales, I.
    Gutierrez, V.
    Duran, G.
    Carabantes-Ocon, F.
    Benavides, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Phase II Study of Nimotuzumab in Combination With Concurrent Chemoradiation Therapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Nishimura, Y.
    Harada, H.
    Soejima, T.
    Tsujino, K.
    Hayakawa, K.
    Kozuka, T.
    Tanaka, M.
    Sasaki, T.
    Yamamoto, N.
    Nakagawa, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S68 - S68
  • [46] A PHASE II STUDY OF CISPLATIN (P), S-1 (S) AND CONCURRENT THORACIC RADIOTHERAPY (TRT) FOR LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER (LA-NSCLC): OKAYAMA LUNG CANCER STUDY GROUP TRIAL 0501
    Nogami, N.
    Kozuki, T.
    Segawa, Y.
    Shinkai, T.
    Maeda, T.
    Ueoka, H.
    Harita, S.
    Kuyama, S.
    Hosokawa, S.
    Gemba, K.
    Takemoto, M.
    Takigawa, N.
    Tabata, M.
    Tanimoto, M.
    Kiura, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 115 - 115
  • [47] Early assessment of liquid biomarkers to predict pneumonitis after chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC)
    Zeng, Jing
    Rengan, Ramesh
    Santana-Davila, Rafael
    Hippe, Daniel S.
    Houghton, Ashley M.
    Kinahan, Paul E.
    Vesselle, Hubert J.
    Lampe, Paul
    Bowen, Stephen R.
    CANCER RESEARCH, 2020, 80 (16)
  • [48] A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancer
    Leong, Swan Swan
    Fong, Kam Weng
    Lim, Wan Teck
    Toh, Chee Keong
    Yap, Swee Peng
    Hee, Siew Wan
    Tan, Eng Huat
    LUNG CANCER, 2010, 67 (03) : 325 - 329
  • [49] Quality of life in poor prognosis patients with locally advanced non-small cell lung cancer (LA-NSCLC) undergoing a phase II study of concurrent cetuximab and definitive thoracic radiotherapy followed by docetaxel and cetuximab.
    Thompson, Lora
    Extermann, Martine
    Dilling, Thomas J.
    Kim, Jongphil
    Yue, Binglin
    Stevens, Craig William
    Antonia, Scott
    Gray, Jhanelle Elaine
    Williams, Charles C.
    Haura, Eric B.
    Pinder, Mary Colleen
    Tanvetyanon, Tawee
    Chiappori, Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Phase II trial of irinotecan plus cisplatin with concurrent thoracic radiotherapy (TRT) in patients with previously untreated locally advanced non-small cell lung cancer (NSCLC)
    Fukuda, M.
    Soda, H.
    Nakamura, Y.
    Fukuda, M.
    Kinoshita, A.
    Nagashima, S.
    Nakano, H.
    Yamaguchi, H.
    Kohno, S.
    Oka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345